7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid

Catalog No. :
ACGANF213
CAS No. :
1268520-63-3
Molecular Formula :
C13H21NO5
Molecular Weight :
271.31

IUPAC Name:7-(tert-butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid

7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$128.00Login to see priceInquiryInquiry
100mg97%$216.00Login to see priceInquiryInquiry
250mg97%$368.00Login to see priceInquiryInquiry
1g97%$792.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid
IUPAC Name7-(tert-butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid
MDL No.MFCD18633022
Molecular FormulaC13H21NO5
Molecular Weight271.31
SMILESO=C(C1OC2(CN(C(OC(C)(C)C)=O)CC2)CC1)O
InChI KeyMSDHAJLDASVPDN-UHFFFAOYSA-N
Synonym7-[(TERT-BUTOXY)CARBONYL]-1-OXA-7-AZASPIRO[4.4]NONANE-2-CARBOXYLIC ACID(WX102180);7-[(TERT-BUTOXY)CARBONYL]-1-OXA-7-AZASPIRO[4.4]NONANE-2-CARBOXYLIC ACID;1-Oxa-7-azaspiro[4.4]nonane-2,7-dicarboxylic acid, 7-(1,1-dimethylethyl) ester
CAS No.1268520-63-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGANF213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGANF213 route product structure diagram
    ACGANF2131268520-63-3
Inquiry

2. ACGANF213 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGANF213 route product structure diagram
    ACGANF2131268520-63-3
Inquiry

Comments (0)